Regulatory Projects

Archives

2025-454 ~ Solicitation of Comments - Pursuant to R.S. 49:964(B), the Board of Pharmacy is soliciting comments on any Rule of the Board [LAC 46:LIII.Chapters 1 through 33] which is believed to be contrary to law, outdated, unnecessary, overly complex, or burdensome.

04-22-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
04-22-2025 - Potpourri submitted to the Louisiana Register for publication on May 20, 2025.
04-22-2025 - Public Hearing scheduled for June 26, 2025, the agenda can be found here.
04-22-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
05-20-2025 - Potpourri published in the May 20, 2025 edition of the Louisiana Register.
05-22-2025 - Second Notice of Rulemaking Activity & Public Hearing distributed.
06-26-2025 - Public Hearing at the Board office.
08-20-2025 - Board scheduled to receive the public comments from the hearing held on June 26, 2025.
08-20-2025 - The matter was referred to the Regulation Revision Committee for consideration and development of recommendations.
10-22-2025 - Regulation Revision Committee scheduled to consider the comments.

2025-10 - Controlled Dangerous Substances (CDS) [Source: Regulatory Proposal 2025-F] - The Board of Pharmacy seeks to amend Chapter 27 of its rules relative to Controlled Dangerous Substances (CDS). The proposed rule changes seek to streamline the regulatory framework by adopting federal regulations by reference, consolidating any provisions that differ from the Code of Federal Regulations (CFR) into Section 2713, and repealing all remaining sections containing redundant requirements.

Proposed Rule - Draft #3 - Coded Version & Clean Version (Current Rule)

08-20-2025 - Board approved Regulatory Proposal 2025-F for promulgation.
10-22-2025 - Regulation Revision Committee scheduled to considered Draft #3, after additional proposed changes idenitifed.

2025-09 - Prescription Monitoring Program (PMP) Record Retention [Source: Regulatory Proposal 2025-D] - The Board of Pharmacy seeks to amend Section 2914 of its rules relative to Prescription Monitoring Program (PMP) record retention. Pursuant to Act 159 of the 2025 Louisiana Legislature, which directs the Board to establish rulemaking standards for the retention, archiving, and destruction of PMP audit trail information, the proposed rule amendment adds audit trail information to the records required to be maintained by the PMP. The amendment also simplifies existing regulatory language.

Proposed Rule - Coded Version & Clean Version (Current Rule)

08-20-2025 - Board approved Regulatory Proposal 2025-D for promulgation.
09-08-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
10-08-2025 - LFO approved FEIS.
10-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
10-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on October 20, 2025.
10-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, October Edition.
10-20-2025 - Public Hearing scheduled for November 26, 2025.
10-20-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
11-26-2025 - Public Hearing at the Board office.

2025-08 - Centralized Prescription Dispensing [Source: Regulatory Proposal 2024-K] - The Board of Pharmacy seeks to amend Section 1141 of its rules relative to Centralized Prescription Dispensing. The proposed rule changes clarify the existing requirements related to prescription labeling and the maintenance of audit trail information. They further establish standards for the delivery of prepared prescriptions between a remote dispenser and an on-site pharmacy. Specifically, the proposed changes require that delivery be conducted in a manner that ensures the integrity of the medication by adhering to nationally recognized standards, and address packaging and temperature control. The proposed rule changes also address possession and control of prescription drugs during delivery, whether by a common carrier, contract carrier, or pharmacy employee, and prohibit the dispensing of any prescription drug compromised in transit. When prescriptions are not dispensed to patients, the proposed rule changes require that they be returned to the remote dispenser pharmacy in situations where the remote dispenser and the on-site pharmacy operate under different ownership. Finally, the proposed rule changes specify that the centralized prescription dispensing of controlled substances must comply with all applicable provisions of federal regulations set forth in 21 CFR Parts 1300 through 1399.

Proposed Rule - Coded Version & Clean Version (Current Rule)

08-20-2025 - Board approved Regulatory Proposal 2024-K for promulgation.
09-08-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
10-08-2025 - LFO approved FEIS.
10-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
10-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on October 20, 2025.
10-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, October Edition.
10-20-2025 - Public Hearing scheduled for November 26, 2025.
10-20-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
11-26-2025 - Public Hearing at the Board office.

2025-07 - Prescription Drug Delivery [Source: Regulatory Proposal 2025-A] - The Board of Pharmacy seeks to amend Section 2501 of its rules to address delivery of prescription drugs to patients. The proposed rule changes add Section 2501.A.4, requiring pharmacies to implement safeguards to protect medication integrity when delivering prescriptions to patients or their authorized agents. These changes address standards, notification, packaging, and temperature control for prescription drug delivery, as well as possession and control of the prescription drug whether the pharmacy uses a common or contract carrier or a pharmacy employee. The proposed rule changes also require pharmacies to replace any prescription drug that is compromised in any way during delivery.

Proposed Rule - Coded Version & Clean Version (Current Rule)

08-20-2025 - Board approved Regulatory Proposal 2025-A for promulgation.
09-04-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
10-08-2025 - LFO approved FEIS.
10-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
10-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on October 20, 2025.
10-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, October Edition.
10-20-2025 - Public Hearing scheduled for November 26, 2025.
10-20-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
11-26-2025 - Public Hearing at the Board office.

2025-06 - Practitioner CDS License [Source: Regulatory Proposal 2025-C] - The Board of Pharmacy seeks to amend Section 2705 of its rules relative to Practitioner CDS Licenses. The proposed rule change is pursuant to Act 444 of the 2022 Regular Session of the Louisiana Legislature which expanded the authority to issue recommendations for medical marijuana to “authorized clinicians,” defined to include physicians, advanced practice registered nurses with prescriptive authority, and medical psychologists. The proposed rule change in Section 2705.C.4 allows “authorized clinicians” as identified in R.S. 40:1046(B) to apply for and be issued a CDS license to authorize the prescription or recommendation of certain substances classified in Schedule I.

Proposed Rule - Coded Version & Clean Version (Current Rule)

02-19-2025 - Board approved Regulatory Proposal 2025-C for promulgation.
03-17-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
04-09-2025 - LFO approved Fiscal and Economic Impact Statement.
04-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
04-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on April 20, 2025.
04-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, April Edition. NOI, as published, can be found here.
04-20-2025 - Public Hearing scheduled for May 27, 2025, the agenda can be found here.
04-21-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
05-27-2025 - Public Hearing at the Board office.
07-17-2025 - Submitted project to the La. Dept. of Justice's Occupational Licensing Review Program (OLRP) for review.
07-17-2025 - 2nd Report submitted to the Joint Legislative Oversight Committee on Health & Welfare and the Louisiana Register.
07-17-2025 - Distributed electronic Notice of Rulemaking Activity.
09-18-2025 - OLRP approved the proposed regulatory project.
09-18-2025 - Submitted Insertion Order to the Louisiana Register for publication of the final Rule.
10-20-2025 - Distributed electronic Notice of Rulemaking Activity in regard to final Rule publication.
10-20-2025 - Final Rule published in the Louisiana Register, effective October 20, 2025.

2025-05 - Nonresident Pharmacy [Source: Regulatory Proposal 2025-B] - The Board of Pharmacy seeks to amend Section 2301 and Section 2307 of its rules relative to Nonresident Pharmacy. The proposed rule change removes the current language in Section 2301.A which may be confusing and unnecessary when compared to current language in Section 2309. The proposed rule change in Section 2307 reduces the minimum experience requirement for a pharmacist to qualify for a Pharmacist-in-Charge (PIC) privilege from two years of active pharmacy practice to one year to align with the PIC requirements in Chapter 11.

Proposed Rule - Coded Version & Clean Version (Current Rule)

02-19-2025 - Board approved Regulatory Proposal 2025-B for promulgation.
03-14-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
04-09-2025 - LFO approved Fiscal and Economic Impact Statement.
04-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
04-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on April 20, 2025.
04-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, April Edition. NOI, as published, can be found here.
04-20-2025 - Public Hearing scheduled for May 27, 2025, the agenda can be found here.
04-21-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
05-27-2025 - Public Hearing at the Board office.
07-17-2025 - Submitted project to the La. Dept. of Justice's Occupational Licensing Review Program (OLRP) for review.
07-17-2025 - 2nd Report submitted to the Joint Legislative Oversight Committee on Health & Welfare and the Louisiana Register.
07-17-2025 - Distributed electronic Notice of Rulemaking Activity.
09-16-2025 - OLRP approved the proposed regulatory project.
09-18-2025 - Submitted Insertion Order to the Louisiana Register for publication of the final Rule.
10-20-2025 - Distributed electronic Notice of Rulemaking Activity in regard to final Rule publication.
10-20-2025 - Final Rule published in the Louisiana Register, effective October 20, 2025.

2025-04 - Emergency Drug Kit (EDK) Permit [Source: Regulatory Proposal 2024-H] - The Board of Pharmacy seeks to amend Section 1711 of its rules relative to Emergency Drug Kit Permits. The proposed Rule change removes the requirement for the administrator of the applicant facility to sign the application for the EDK permit, and require the online permit verification to be readily retrievable, since the Board no longer issues paper permits.

Proposed Rule - Coded Version & Clean Version (Current Rule)

11-20-2024 - Board approved Regulatory Proposal 2024-H for promulgation.
01-10-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
02-10-2025 - LFO approved Fiscal and Economic Impact Statement.
02-10-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
02-10-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on February 20, 2025.
02-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, February Edition. NOI, as published, can be found here.
02-20-2025 - Public Hearing scheduled for March 31, 2025, the agenda can be found here.
02-20-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
03-07-2025 - Annual Report on Rulemaking Activities for calendar year 2024 submitted.
03-31-2025 - Public Hearing at the Board office.
03-31-2025 - Submitted project to the La. Dept. of Justice's Occupational Licensing Review Program (OLRP) for review.
03-31-2025 - 2nd Report submitted to the Joint Legislative Oversight Committee on Health & Welfare and the Louisiana Register.
03-31-2025 - Distributed electronic Notice of Rulemaking Activity.
05-27-2025 - OLRP approved the proposed regulatory project.
05-27-2025 - Submitted Insertion Order to the Louisiana Register for publication of the final Rule.
06-20-2025 - Distributed electronic Notice of Rulemaking Activity in regard to final Rule publication.
06-20-2025 - Final Rule published in the Louisiana Register, effective June 20, 2025.

2025-03 - Pharmacy Technician Certificate Qualifications [Source: Regulatory Proposal 2024-J] - The Board of Pharmacy seeks to amend Section 905 of its rules relative to pharmacy technician certificate qualifications. In response to Act 253 of the 2024 Louisiana Legislature, the proposed rule change removes the practice requirement placed upon a pharmacy technician applicant from another state and recognizes the exception provided by the Act regarding the examination requirement.

Proposed Rule - Coded Version (Draft #2) & Clean Version (Draft #2) (Current Rule)

11-20-2024 - Board approved Regulatory Proposal 2024-J for promulgation.
01-10-2025 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
01-16-2025 - Request to the LFO to pause FEIS review.
02-06-2025 - Project scheduled for review by the Regulation Revision Committee. Draft #2
02-06-2025 - Regulation Revision Committee approved Draft #2 for consideration by the Board.
02-19-2025 - Board scheduled to consider Draft #2 .
02-19-2025 - Board approved Draft #2 .
03-03-2025 - FEIS submitted to the LFO for approval.
03-07-2025 - Annual Report on Rulemaking Activities for calendar year 2024 submitted.
04-09-2025 - LFO approved Fiscal and Economic Impact Statement.
04-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
04-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on April 20, 2025.
04-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, April Edition. NOI, as published, can be found here.
04-20-2025 - Public Hearing scheduled for May 27, 2025, the agenda can be found here.
04-21-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
05-27-2025 - Public Hearing at the Board office.
07-17-2025 - Submitted project to the La. Dept. of Justice's Occupational Licensing Review Program (OLRP) for review.
07-17-2025 - 2nd Report submitted to the Joint Legislative Oversight Committee on Health & Welfare and the Louisiana Register.
07-17-2025 - Distributed electronic Notice of Rulemaking Activity.
08-25-2025 - OLRP approved the proposed regulatory project.
09-18-2025 - Submitted Insertion Order to the Louisiana Register for publication of the final Rule.
10-20-2025 - Distributed electronic Notice of Rulemaking Activity in regard to final Rule publication.
10-20-2025 - Final Rule published in the Louisiana Register, effective October 20, 2025.

2025-02 - Marijuana Pharmacy [Source: Regulatory Proposal 2024-I] - The Board of Pharmacy seeks to repeal Chapter 24, Subchapter E of its rules relative to Marijuana Pharmacy pursuant to Act 693 of the 2024 Regular Session of the Legislature which transfers regulatory authority for therapeutic marijuana from the Board of Pharmacy to the Louisiana Department of Health.

Proposed Rule - Coded Version & Clean Version (Current Rule)

11-20-2024 - Board approved Regulatory Proposal 2024-I for promulgation.
12-13-2024 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
01-09-2025 - LFO approved fiscal and economic impact statement.
01-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
01-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on January 20, 2025.
01-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, January Edition. NOI, as published, can be found here.
01-20-2025 - Public Hearing scheduled for February 26, 2025, the agenda can be found here.
01-20-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
02-26-2025 - Public Hearing at the Board office.
03-07-2025 - Annual Report on Rulemaking Activities for calendar year 2024 submitted.
03-14-2025 - 2nd Report submitted to the Joint Legislative Oversight Committee on Health & Welfare and the Louisiana Register.
03-14-2025 - Distributed electronic Notice of Rulemaking Activity.
05-08-2025 - Submitted Insertion Order to the Louisiana Register for publication of the final Rule.
05-20-2025 - Distributed electronic Notice of Rulemaking Activity in regard to final Rule publication.
05-20-2025 - Final Rule published in the Louisiana Register, effective May 20, 2025.

2025-01 - Pharmacist-in-Charge (PIC) Requirements [Source: Regulatory Proposal 2024-G] - The Board of Pharmacy seeks to amend Section 1105 of its rules relative to Pharmacist-in-Charge (PIC). The proposed Rule change in Section 1105.A reduces the minimum experience requirement for a pharmacist to qualify for a PIC privilege from two years of active pharmacy practice to one year. The proposed Rule change in Section 1105.C adds the authority and accountability of the owner of the pharmacy permit to the existing responsibility of the PIC for the complete supervision, management, and compliance with laws and regulations pertaining to the practice of pharmacy of the entire prescription department.

Proposed Rule - Coded Version & Clean Version (Current Rule)

11-20-2024 - Board approved Regulatory Proposal 2024-G for promulgation.
12-13-2024 - Fiscal & Economic Impact Statement (FEIS) submitted to the Legislative Fiscal Office (LFO) for approval.
01-09-2025 - LFO approved fiscal and economic impact statement.
01-09-2025 - 1st Report submitted to the Joint Legislative Oversight Committee on Health & Welfare.
01-09-2025 - Notice of Intent (NOI) submitted to the Louisiana Register for publication on January 20, 2025.
01-20-2025 - NOI published in the 2025 Louisiana Register, Volume 51, January Edition. NOI, as published, can be found here.
01-20-2025 - Public Hearing scheduled for February 26, 2025, the agenda can be found here.
01-20-2025 - Notice of Rulemaking Activity & Public Hearing distributed.
02-26-2025 - Public Hearing at the Board office.
03-05-2025 - Submitted project to the La. Dept. of Justice's Occupational Licensing Review Program (OLRP) for review.
03-07-2025 - Annual Report on Rulemaking Activities for calendar year 2024 submitted.
03-14-2025 - 2nd Report submitted to the Joint Legislative Oversight Committee on Health & Welfare and the Louisiana Register.
03-14-2025 - Distributed electronic Notice of Rulemaking Activity.
05-12-2025 - OLRP approved the proposed regulatory project.
05-23-2025 - Submitted Insertion Order to the Louisiana Register for publication of the final Rule.
06-20-2025 - Distributed electronic Notice of Rulemaking Activity in regard to final Rule publication.
06-20-2025 - Final Rule published in the Louisiana Register, effective June 20, 2025.